Premium Information is available for this item - Upgrade for $1 a day
6505-01-373-2802
Dantrolene Sodium For Injection
6505013732802 013732802 NDC00149-0734-02 73402
INC: 37569 Dantrolene Sodium For Injection
January 2023
3
Marketplace 6505-01-373-2802
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-373-2802 5+ Documents (More...)
6505-01-373-2802 RQST NE Related Documents For Injection 013732802 to 6505-01-373 Dantrolene Sodium
Dantrolene Sodium For Injection 013732802 Injection 016531569 Related to 6505-01-373-2802 https
Sodium For Injection 171190481 Sodium For Injection 171190481 17-119-0481 /fsg https For Injection 013732802
Injection 016531569 Related to 6505-01-373-2802 https Sodium For Injection 171190481 https//www.nsnlookup.com
Dantrolene Sodium For Injection 013732802 Injection 171190481 https 6505/us 6505-01-373-2802 https
Reference RNCC 5 RNVC 1 DAC 4 NATO Stock Numbers Related to 6505-21-882-9194 6505-17-119-0481 6505-01-373-2802
Dantrolene Sodium For Injection 013732802 9194 5+ Documents https 6505/us 6505-01-373-2802 https
fsg-65/fsc-6505/us 6505-01-239-6963 Dantrolene Sodium For Injection 012396963 6505-17-119-0481 6505-01-373-2802
//www.nsnlookup.com /fsg-53/fsc-5365/fr 5365-14-433-1493 Lot Bagues D'arret 5365144331493144331493 73402
Dantrolene Sodium For Injection 013732802 Account Upgrade 6505-01-373-2802Dantrolene Sodium For
Restrictions 6505-01-373-2802
6505-01-373-2802 is a Dantrolene Sodium For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-373-2802
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-373-2802
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-373-2802
- Part Number
- Manufacturer
- Status
- NDC00149-0734-02
- Manufacturer
- 04547 - Procter & Gamble Pharmaceuticals, (Active)
- Incomplete Reference
- Incomplete Reference
- 73402
- 04547 - Procter & Gamble Pharmaceuticals, (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-373-2802
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- 20.000 Milligrams Dantrolene Sodium Active Ingredient
- Physical Form [AGXW]
- Powder
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 20 Milligrams Active Ingredient
- Total Primary Container Quantity [CSCW]
- 6
- Special Features [FEAT]
- Contains 3000 Mg Mannito And Sufficient Sodium Hydroxide To Yield A Ph Of Approx. 9.5; For Reconstitution Water For Injection Without Bacteriostatic Agent; For Treatment Of Malignant Hyperthermia
Management Data 6505-01-373-2802
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 1993
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 12 Ea
- 00000000012EA
- K
Similar Supply Items to 6505-01-373-2802
Freight Information 6505-01-373-2802
6505-01-373-2802 has freight characteristics.. 6505-01-373-2802 has a variance between NMFC and UFC when transported by rail and the description should be consulted.